Search

Displaying results 1951 - 1960 of 10000 in total
  1. Drug

    Nonivamide

    go.drugbank.com/drugs/DB11324
    Approved

    The structures of [DB06774] and nonivamide differ only slightly with respect to the fatty acid moiety of the side chain (8-methyl nonenoic acid versus nonanoic acid) [F31]. … Nonivamide is found in herbs and spices. It is an alkaloid from the Capsicum species.

    Mixtures: Nonivamid + Nicoboxil Zentiva 4 mg/g + 25 mg/g SalbeSynonyms: N-Vanillylnonamide, N-Nonanoyl vanillylamide
  2. Drug

    Bamlanivimab

    go.drugbank.com/drugs/DB15718
    ApprovedInvestigational

    [L20979] Based on phase 2 clinical trial (BLAZE-1) interim results, bamlanivimab was granted Emergency Use Authorization (EUA) by the FDA on November 10, 2020. … it in collaboration with Eli Lilly and Company.

  3. Drug

    Fotemustine

    go.drugbank.com/drugs/DB04106
    Investigational

    Products: MUPHORAN 208 MG FLAKON, 1 ADET, Muphoran 200 mg/4ml Pulver und Lösungsmittel zur Herstellung einer Infusionslösung
  4. Drug

    Threonine

    go.drugbank.com/drugs/DB00156
    ApprovedInvestigationalNutraceutical

    An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.

    Mixtures: LEVAMIN 80 CR, POLİNUTHREE EN-550 ELEKTROLİTLİ AMİNOASİT ÇÖZELTİSİ, GLUKOZ ÇÖZELTİSİ, VE LİPİD EMÜLSİYONU, 1000 ML
  5. Drug

    Difluocortolone

    go.drugbank.com/drugs/DB09095
    ApprovedWithdrawn

    It is commonly used in dermatology for the reduction of inflammation and itching. It was submitted to the FDA in July 1984 by the pharmaceutical company Schering AG.[L1082]

    Mixtures: TRODERM 10 MG/G+1 MG/G KREM ,15 G, TİNAGEN 1 MG+10 MG/1 G DERİ KREMİ, 15 GProducts: NERIFORTE POMAD, 10 G, TEMETEX %01 KREM, 10 G
  6. Drug

    Mosunetuzumab

    go.drugbank.com/drugs/DB15434
    ApprovedInvestigational

    [L42245] In June 2022, the European Medicines Agency approved mosunetuzumab for the treatment of adult patients with relapsed or refractory (R/R) FL who have received at least two prior systemic therapies … [L42245] In January 2023, the FDA granted accelerated approval to intravenous mosunetuzumab based on response rate.

    Products: Lunsumio 1mg/ml Concentrate for Solution for Infusion
  7. Drug

    Piribedil

    go.drugbank.com/drugs/DB12478
    Investigational

    Piribedil has been investigated in Parkinson's Disease.

    Products: TRIVASTAL RETARD 50 TABLET 50 mg, TRIVASTAL 50 MG RETARD TABLET, 30 ADET
  8. Drug

    Isoflavone

    go.drugbank.com/drugs/DB12007
    ApprovedInvestigationalWithdrawn

    Soybean is an exceptionally rich source of dietary isoflavones, where the average isoflavone content is 1-2 mg/gram [A33103]. … The main soy isoflavones are mostly present in glycosylated forms and include [DB01645], [DB13182], and glycitein, which accounts for approximately 50%, 40%, and 10%, respectively, of the total soybean

  9. Drug

    Morinamide

    go.drugbank.com/drugs/DB13417
    Investigational

    Products: MORFOZID 500 MG TABLET, 50 ADET, MORFOZID 500 MG TABLET, 500 ADET
  10. Drug

    Ferric sulfate

    go.drugbank.com/drugs/DB11171
    Approved

    It is produced by the reaction of sulfuric acid and an oxidizing agent. … [A32355, A32356] By the FDA, ferric sulfate is a direct food substance affirmed in the GRAS category (Generally Recognized As Safe).[L2003]

    Products: Statis Hemostyptic Soln 210mg/ml